跳至主要内容
临床试验/IRCT138806181141N6
IRCT138806181141N6已完成3 期

Administration of methylprednisolone for prevention of ovarian hyperstimulation syndrome in in-vitro fertilization cycles

Royan Institute0 个研究点目标入组 218 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
218

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 35 years(—)
性别
Female

入选标准

  • Inclusion Criteria: 1.Poly Cystic Ovarian Syndrome patients 2.Indication for IVF/ICSI and Long Protocol ovarian stimulation 3.Age<35 4.Basal FSH=10 5.Normal BMI (20-25) 6.Physical health

排除标准

  • 1. Allergy to GnRH analogues, FSH and corticosteroids 2. presence of heart failure, recent myocardial infarction, Hypertension, Diabetes mellitus, epilepsy, glaucoma, hypothyroidism, hepatic failure, osteoporosis, peptic ulceration, psychosis, or severe affective disorders and renal impairment. 3. Using drugs that have interaction with corticosteroids such as Cyclosporine, Phenobarbital, Phenytoin, Rifampin, Ketoconazole, Aspirin and Anticoagulants (All of these drugs shouldn’t be used during recent 2 weeks prior to the study and during corticosteroids consumption)

研究者

相似试验

Administration of Methylprednisolone in prevention... | 临床试验